Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 898 | 875 | 1,299 | 1,614 | 1,950 |
| Gross Profit | 898 | 875 | 1,299 | 1,614 | 1,950 |
| Operating Expenses | 45,861 | 43,178 | 43,507 | 48,665 | 48,799 |
| Operating Income | -44,963 | -42,303 | -42,208 | -47,051 | -46,849 |
| Other Income | 2,235 | 2,624 | 3,136 | 3,571 | 3,924 |
| Pre-tax Income | -42,728 | -39,679 | -39,072 | -43,480 | -42,925 |
| Income Tax | 35 | 38 | 92 | 654 | 178 |
| Net Income Continuous | -42,763 | -39,717 | -39,164 | -44,134 | -43,103 |
| Net Income | $-42,763 | $-39,717 | $-39,164 | $-44,134 | $-43,103 |
| EPS Basic Total Ops | -1.01 | -0.95 | -0.95 | -1.06 | -1.04 |
| EPS Basic Continuous Ops | -1.01 | -0.95 | -0.95 | -1.06 | -1.04 |
| EPS Diluted Total Ops | -1.01 | -0.95 | -0.95 | -1.06 | -1.04 |
| EPS Diluted Continuous Ops | -1.01 | -0.95 | -0.95 | -1.06 | -1.04 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.95 | -0.94 | -1.06 | -1.04 |
| EBITDA(a) | $-44,572 | $-42,046 | $-41,955 | $-46,560 | $-46,776 |